J.W. COLE ADVISORS, INC. - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 164 filers reported holding THERAPEUTICSMD INC in Q1 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
J.W. COLE ADVISORS, INC. ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$5,000
+25.0%
11,9410.0%0.00%
Q4 2021$4,000
-63.6%
11,941
-20.1%
0.00%
-100.0%
Q3 2021$11,000
-38.9%
14,9410.0%0.00%0.0%
Q2 2021$18,000
-21.7%
14,941
-11.8%
0.00%
-50.0%
Q1 2021$23,00016,9410.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2021
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 3,560,816$2,641,0000.48%
Rubric Capital Management LP 5,344,302$3,962,0000.11%
Birchview Capital, LP 100,000$74,0000.05%
C WorldWide Group Holding A/S 6,189,834$4,589,0000.05%
MCDONALD PARTNERS LLC 226,000$168,0000.04%
Traynor Capital Management, Inc. 367,991$272,0000.04%
Platform Technology Partners 100,000$74,0000.03%
EMFO, LLC 44,500$33,0000.03%
Knights of Columbus Asset Advisors LLC 365,105$271,0000.02%
Kowal Investment Group, LLC 98,631$73,0000.02%
View complete list of THERAPEUTICSMD INC shareholders